Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jost

Showing results (371-380 of 384) with videos related to

Pageof 39
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|September 23, 2025
Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus viewKarolina Poplawska-Domaszewicz, Valtteri Kaasinen, Anton Adriaan van der Plas, et al.
The Journal of Molecular Diagnostics : JMD|December 15, 2019
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I-IV Non-Small Cell Lung CancerJohn Jiang, Hans-Peter Adams, Lijing Yao, et al.
Brain : a Journal of Neurology|February 22, 2025
Hippocampus and basal forebrain degeneration differentially impact cognition in Lewy body spectrum disordersAlexander Rau, Lea Philipsen, Lars Frings, et al.
Frontiers in Neurology|January 1, 2024
Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendationsWolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2016
Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trialWerner Poewe, Pierre Burbaud, Giovanni Castelnovo, et al.
Neurology and Therapy|May 7, 2026
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim ResultsWolfgang H Jost, Filip Bergquist, Andrew Evans, et al.
Journal of Parkinson'S Disease|June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathyLan Ye, Stephan Greten, Ida Wilkens, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 2, 2004
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind studyM Graf, D Ecker, R Horowski, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Science (New York, N.Y.)|February 13, 2001
The detection of large HNO3-containing particles in the winter Arctic stratosphereD W Fahey, R S Gao, K S Carslaw, et al.
Pageof 39

Showing results (371-380 of 384) with videos related to

Sort By:
Pageof 39
Journal of Neural Transmission (Vienna, Austria : 1996)|September 23, 2025
Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus viewKarolina Poplawska-Domaszewicz, Valtteri Kaasinen, Anton Adriaan van der Plas, et al.
The Journal of Molecular Diagnostics : JMD|December 15, 2019
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I-IV Non-Small Cell Lung CancerJohn Jiang, Hans-Peter Adams, Lijing Yao, et al.
Brain : a Journal of Neurology|February 22, 2025
Hippocampus and basal forebrain degeneration differentially impact cognition in Lewy body spectrum disordersAlexander Rau, Lea Philipsen, Lars Frings, et al.
Frontiers in Neurology|January 1, 2024
Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendationsWolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2016
Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trialWerner Poewe, Pierre Burbaud, Giovanni Castelnovo, et al.
Neurology and Therapy|May 7, 2026
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim ResultsWolfgang H Jost, Filip Bergquist, Andrew Evans, et al.
Journal of Parkinson'S Disease|June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathyLan Ye, Stephan Greten, Ida Wilkens, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 2, 2004
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind studyM Graf, D Ecker, R Horowski, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Science (New York, N.Y.)|February 13, 2001
The detection of large HNO3-containing particles in the winter Arctic stratosphereD W Fahey, R S Gao, K S Carslaw, et al.
Pageof 39